A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.

This bill appears to deal with making the process clearer and more predictable when drug companies want to switch a medication from prescription-only (Rx) to available without a prescription (over-the-counter). No official summary is available for this bill.

Your Vote